Suppr超能文献

噬菌体与真核细胞之间的相互作用。

Interactions between Bacteriophages and Eukaryotic Cells.

作者信息

Putra Ramendra Dirgantara, Lyrawati Diana

机构信息

Department of Pharmacy, Faculty of Medicine, Brawijaya University, Malang 65145, Indonesia.

出版信息

Scientifica (Cairo). 2020 Jun 9;2020:3589316. doi: 10.1155/2020/3589316. eCollection 2020.

Abstract

As the name implies, bacteriophage is a bacterium-specific virus. It infects and kills the bacterial host. Bacteriophages have gained attention as alternative antimicrobial entities in the science community in the western world since the alarming rise of antibiotic resistance among microbes. Although generally considered as prokaryote-specific viruses, recent studies indicate that bacteriophages can interact with eukaryotic organisms, including humans. In the current review, these interactions are divided into two categories, i.e., indirect and direct interactions, with the involvement of bacteriophages, bacteria, and eukaryotes. We discuss bacteriophage-related diseases, transcytosis of bacteriophages, bacteriophage interactions with cancer cells, collaboration of bacteriophages and eukaryotes against bacterial infections, and horizontal gene transfer between bacteriophages and eukaryotes. Such interactions are crucial for understanding and developing bacteriophages as the therapeutic agents and pharmaceutical delivery systems. With the advancement and combination of in silico, , and approaches and clinical trials, bacteriophages definitely serve as useful repertoire for biologic target-based drug development to manage many complex diseases in the future.

摘要

顾名思义,噬菌体是一种专门感染细菌的病毒。它感染并杀死细菌宿主。自从微生物中抗生素耐药性惊人地上升以来,噬菌体作为替代抗菌实体在西方科学界受到了关注。尽管通常被认为是原核生物特有的病毒,但最近的研究表明,噬菌体可以与包括人类在内的真核生物相互作用。在当前的综述中,这些相互作用分为两类,即间接相互作用和直接相互作用,涉及噬菌体、细菌和真核生物。我们讨论了与噬菌体相关的疾病、噬菌体的转胞吞作用、噬菌体与癌细胞的相互作用、噬菌体与真核生物对抗细菌感染的协作,以及噬菌体与真核生物之间的水平基因转移。此类相互作用对于理解和开发噬菌体作为治疗剂和药物递送系统至关重要。随着计算机模拟、[此处原文缺失部分内容]和[此处原文缺失部分内容]方法以及临床试验的进步与结合,噬菌体肯定会成为基于生物靶点的药物开发的有用资源,以在未来治疗许多复杂疾病。

相似文献

1
Interactions between Bacteriophages and Eukaryotic Cells.
Scientifica (Cairo). 2020 Jun 9;2020:3589316. doi: 10.1155/2020/3589316. eCollection 2020.
2
Bacteriophage Transcytosis Provides a Mechanism To Cross Epithelial Cell Layers.
mBio. 2017 Nov 21;8(6):e01874-17. doi: 10.1128/mBio.01874-17.
3
An Overview of Antiviral Properties of Bacteriophages with Emphasis on the Treatment of COVID-19 Infection.
Infect Disord Drug Targets. 2022;22(6):e240122200472. doi: 10.2174/1871526522666220124110547.
4
Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics.
Recent Pat Biotechnol. 2021;15(1):25-33. doi: 10.2174/1872208315666210121094311.
5
Phage Therapy as a Protective Tool Against Pathogenic Bacteria: How Far We Are?
Curr Pharm Biotechnol. 2023;24(10):1277-1290. doi: 10.2174/1389201024666221207114047.
6
Treating bacterial infections with bacteriophages in the 21st century.
S Afr J Infect Dis. 2022 Mar 29;37(1):346. doi: 10.4102/sajid.v37i1.346. eCollection 2022.
7
Bacteriophage-Mediated Cancer Gene Therapy.
Int J Mol Sci. 2022 Nov 17;23(22):14245. doi: 10.3390/ijms232214245.
8
A first step toward liposome-mediated intracellular bacteriophage therapy.
Expert Opin Drug Deliv. 2015;12(9):1411-24. doi: 10.1517/17425247.2015.1043125. Epub 2015 May 2.
9
Basic Guidelines for Bacteriophage Isolation and Characterization.
Recent Pat Biotechnol. 2023;17(4):312-331. doi: 10.2174/1872208317666221017094715.
10
Engineering bacteriophages for enhanced host range and efficacy: insights from bacteriophage-bacteria interactions.
Front Microbiol. 2023 May 31;14:1172635. doi: 10.3389/fmicb.2023.1172635. eCollection 2023.

引用本文的文献

1
3
Optimizing bacteriophage treatment of resistant .
mSphere. 2024 Jul 30;9(7):e0070723. doi: 10.1128/msphere.00707-23. Epub 2024 Jun 27.
4
Phage Therapy, a Salvage Treatment for Multidrug-Resistant Bacteria Causing Infective Endocarditis.
Biomedicines. 2023 Oct 22;11(10):2860. doi: 10.3390/biomedicines11102860.
5
Activity of a Bacteriophage Cocktail to Control Growth in Avian, Porcine, and Human Epithelial Cell Cultures.
Phage (New Rochelle). 2023 Mar 1;4(1):11-25. doi: 10.1089/phage.2023.0001. Epub 2023 Mar 17.
6
An Overview of the Public Health Challenges in Diagnosing and Controlling Human Foodborne Pathogens.
Vaccines (Basel). 2023 Mar 24;11(4):725. doi: 10.3390/vaccines11040725.
7
In Vitro Anti- Mode of Action of and .
Microorganisms. 2023 Feb 27;11(3):602. doi: 10.3390/microorganisms11030602.
9
Adaptive lifestyle of bacteria determines phage-bacteria interaction.
Front Microbiol. 2022 Dec 6;13:1056388. doi: 10.3389/fmicb.2022.1056388. eCollection 2022.
10
Recent Advances in the Application of Bacteriophages against Common Foodborne Pathogens.
Antibiotics (Basel). 2022 Nov 2;11(11):1536. doi: 10.3390/antibiotics11111536.

本文引用的文献

1
Phage therapy: awakening a sleeping giant.
Emerg Top Life Sci. 2017 Apr 21;1(1):93-103. doi: 10.1042/ETLS20170002.
3
Eye-Tracking Test Approved to Help Diagnose Concussion.
JAMA. 2019 Feb 19;321(7):638. doi: 10.1001/jama.2019.0509.
4
Bacteriophages of the Human Gut: The "Known Unknown" of the Microbiome.
Cell Host Microbe. 2019 Feb 13;25(2):195-209. doi: 10.1016/j.chom.2019.01.017.
5
Bacteriophage interactions with mammalian tissue: Therapeutic applications.
Adv Drug Deliv Rev. 2019 May;145:4-17. doi: 10.1016/j.addr.2019.01.003. Epub 2019 Jan 17.
6
Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System.
Viruses. 2018 Dec 25;11(1):10. doi: 10.3390/v11010010.
7
Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles.
Front Cell Infect Microbiol. 2018 Oct 23;8:376. doi: 10.3389/fcimb.2018.00376. eCollection 2018.
9
Thermoresponsive Bacteriophage Nanocarrier as a Gene Delivery Vector Targeted to the Gastrointestinal Tract.
Mol Ther Nucleic Acids. 2018 Sep 7;12:33-44. doi: 10.1016/j.omtn.2018.04.012. Epub 2018 May 1.
10
Parkinson's disease and bacteriophages as its overlooked contributors.
Sci Rep. 2018 Jul 17;8(1):10812. doi: 10.1038/s41598-018-29173-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验